Patents by Inventor Alex Hemeryck

Alex Hemeryck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITION OF BONE RESORPTION WITH RANKL BINDING PEPTIDES
    Publication number: 20170253652
    Abstract: Methods are provided for inhibiting bone resorption and/or osteoclast activity. More specifically, methods are provided wherein polypeptides against RANK-L are administered to a subject less frequently and/or at lower dose, while still maintaining effective inhibition of bone resorption and/or osteoclast activity in the subject at unexpectedly prolonged periods of time, particularly in view of the doses administered.
    Type: Application
    Filed: October 17, 2016
    Publication date: September 7, 2017
    Applicant: Ablynx N.V.
    Inventors: JOSEFIN-BEATE HOLZ, Alex Hemeryck
  • Inhibition of bone resorption with RANKL binding peptides
    Patent number: 9505840
    Abstract: Methods are provided for inhibiting bone resorption and/or osteoclast activity. More specifically, methods are provided wherein polypeptides against RANK-L are administered to a subject less frequently and/or at lower dose, while still maintaining effective inhibition of bone resorption and/or osteoclast activity in the subject at unexpectedly prolonged periods of time, particularly in view of the doses administered.
    Type: Grant
    Filed: May 29, 2012
    Date of Patent: November 29, 2016
    Assignee: Ablynx N.V.
    Inventors: Josefin-Beate Holz, Alex Hemeryck
  • Inhibition of Bone Resorption with Rankl Binding Peptides
    Publication number: 20140170167
    Abstract: Methods are provided for inhibiting bone resorption and/or osteoclast activity. More specifically, methods are provided wherein polypeptides against RANK-L are administered to a subject less frequently and/or at lower dose, while still maintaining effective inhibition of bone resorption and/or osteoclast activity in the subject at unexpectedly prolonged periods of time, particularly in view of the doses administered.
    Type: Application
    Filed: May 29, 2012
    Publication date: June 19, 2014
    Applicant: Ablynx N.V.
    Inventors: Josefin-Beate Holz, Alex Hemeryck